These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30242706)

  • 21. Detection of ubiquitination activity and identification of ubiquitinated substrates using TR-TUBE.
    Yoshida Y; Saeki Y; Tsuchiya H; Tanaka K
    Methods Enzymol; 2019; 618():135-147. PubMed ID: 30850049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
    Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
    Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of Ubiquitination in Differentiation and Dedifferentiation of Pancreatic β-cells: Putative Target for Diabetes.
    Francis M; Bhaskar S; Vishnuvajhala S; Prasanna J; Kumar A
    Curr Protein Pept Sci; 2022; 23(9):602-618. PubMed ID: 35466872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance.
    Kubaichuk K; Kietzmann T
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to Trap Enzyme-Substrate Complexes that Mimic Michaelis Intermediates During E3-Mediated Ubiquitin-Like Protein Ligation.
    Streich FC; Lima CD
    Methods Mol Biol; 2018; 1844():169-196. PubMed ID: 30242710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using In Vitro Ubiquitylation Assays to Estimate the Affinities of Ubiquitin-Conjugating Enzymes for Their Ubiquitin Ligase Partners.
    Hill S; Hill C; Kleiger G
    Methods Mol Biol; 2018; 1844():39-58. PubMed ID: 30242702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recycling and Reshaping-E3 Ligases and DUBs in the Initiation of T Cell Receptor-Mediated Signaling and Response.
    Cammann C; Israel N; Slevogt H; Seifert U
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases.
    Estavoyer B; Messmer C; Echbicheb M; Rudd CE; Milot E; Affar EB
    J Biol Chem; 2022 Aug; 298(8):102198. PubMed ID: 35764170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
    Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifaceted N-Degron Recognition and Ubiquitylation by GID/CTLH E3 Ligases.
    Chrustowicz J; Sherpa D; Teyra J; Loke MS; Popowicz GM; Basquin J; Sattler M; Prabu JR; Sidhu SS; Schulman BA
    J Mol Biol; 2022 Jan; 434(2):167347. PubMed ID: 34767800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site.
    Paiva SL; da Silva SR; de Araujo ED; Gunning PT
    J Med Chem; 2018 Jan; 61(2):405-421. PubMed ID: 28076680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic Assembly of Ubiquitin Chains.
    Michel MA; Komander D; Elliott PR
    Methods Mol Biol; 2018; 1844():73-84. PubMed ID: 30242704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncovalent Ubiquitin Interactions Regulate the Catalytic Activity of Ubiquitin Writers.
    Wright JD; Mace PD; Day CL
    Trends Biochem Sci; 2016 Nov; 41(11):924-937. PubMed ID: 27614784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers.
    Park HB; Baek KH
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188736. PubMed ID: 35589008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of mTOR signaling by ubiquitin.
    Jiang Y; Su S; Zhang Y; Qian J; Liu P
    Oncogene; 2019 May; 38(21):3989-4001. PubMed ID: 30705402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities.
    Kumar S; Basu M; Ghosh MK
    Biochim Biophys Acta Mol Cell Res; 2024 Dec; 1871(8):119827. PubMed ID: 39187067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deubiquitylating enzymes: potential target in autoimmune diseases.
    Parihar N; Bhatt LK
    Inflammopharmacology; 2021 Dec; 29(6):1683-1699. PubMed ID: 34792672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.
    Liu F; Chen J; Li K; Li H; Zhu Y; Zhai Y; Lu B; Fan Y; Liu Z; Chen X; Jia X; Dong Z; Liu K
    Mol Cancer; 2024 Jul; 23(1):148. PubMed ID: 39048965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.